Hbk Sorce Advisory LLC Viatris Inc Transaction History

Hbk Sorce Advisory LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$9.2 - $12.26 $53,470 - $71,255	-5,812 Reduced 25.84%	16,682 $243,000
Q4 2022 Feb 09, 2023	BUY	$8.72 - $11.56 $106,532 - $141,228	12,217 Added 118.88%	22,494 $250,000
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $1,238 - $1,624	-146 Reduced 1.4%	10,277 $88,000
Q2 2022 Aug 15, 2022	SELL	$9.95 - $12.27 $11,601 - $14,306	-1,166 Reduced 10.06%	10,423 $109,000
Q1 2022 May 13, 2022	SELL	$9.81 - $15.4 $7,573 - $11,888	-772 Reduced 6.25%	11,589 $126,000
Q4 2021 Feb 15, 2022	SELL	$12.09 - $14.68 $4,654 - $5,651	-385 Reduced 3.02%	12,361 $167,000
Q3 2021 Nov 15, 2021	BUY	$13.25 - $15.13 $20,034 - $22,876	1,512 Added 13.46%	12,746 $173,000
Q2 2021 Aug 12, 2021	BUY	$12.97 - $16.15 $14,137 - $17,603	1,090 Added 10.75%	11,234 $161,000
Q1 2021 May 14, 2021	BUY	$13.59 - $18.54 $137,856 - $188,069	10,144 New	10,144 $142,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Hbk Sorce Advisory LLC with notifications on news.